Science ❯ Biomedical Research ❯ Vaccine Development ❯ mRNA Technology

Clinical Trials

FDA Approves LP.8.1 COVID Boosters, Limits Routine Use to Seniors and High-Risk Patients

Uncertainty over CDC guidance now clouds insurance coverage.

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Moderna Secures $176 Million for mRNA Bird Flu Vaccine Amid Rising Pandemic Concerns